Barnes Dennig Private Wealth Management LLC Invests $2.07 Million in CVS Health Corporation (NYSE:CVS)

Barnes Dennig Private Wealth Management LLC purchased a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 30,474 shares of the pharmacy operator's stock, valued at approximately $2,065,000. CVS Health accounts for approximately 3.1% of Barnes Dennig Private Wealth Management LLC's investment portfolio, making the stock its 11th biggest position.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CVS. Hopwood Financial Services Inc. acquired a new stake in shares of CVS Health in the 4th quarter valued at approximately $29,000. McIlrath & Eck LLC raised its position in CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares in the last quarter. MV Capital Management Inc. boosted its position in shares of CVS Health by 63.9% during the 1st quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock worth $50,000 after purchasing an additional 289 shares in the last quarter. Dunhill Financial LLC grew its stake in shares of CVS Health by 147.2% during the 1st quarter. Dunhill Financial LLC now owns 749 shares of the pharmacy operator's stock worth $51,000 after purchasing an additional 446 shares during the period. Finally, Atwood & Palmer Inc. increased its holdings in shares of CVS Health by 228.0% in the 1st quarter. Atwood & Palmer Inc. now owns 820 shares of the pharmacy operator's stock valued at $56,000 after purchasing an additional 570 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at CVS Health

In related news, Director Guy P. Sansone bought 1,570 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was purchased at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the acquisition, the director owned 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.22% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

CVS has been the topic of a number of research analyst reports. Cowen reissued a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Barclays set a $79.00 price target on CVS Health and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Mizuho raised their price objective on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, UBS Group raised their price target on CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a research report on Friday, May 2nd. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $75.06.

CVS Health Trading Up 0.8%

Shares of CVS traded up $0.58 on Tuesday, hitting $69.56. 5,667,444 shares of the stock traded hands, compared to its average volume of 10,814,660. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $72.51. The stock's 50 day moving average is $64.93 and its two-hundred day moving average is $61.07. The firm has a market capitalization of $87.99 billion, a P/E ratio of 16.60, a P/E/G ratio of 0.98 and a beta of 0.56. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The business's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.31 EPS. As a group, sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.